StockData
Lineage Cell Therapeutics, Inc. logo

Lineage Cell Therapeutics, Inc. (LCTX) fundamentals chart

LCTXNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3024% above fair value
$0.84+0.02 (+2.78%)

Close on Nov 18, 2026Market cap $212.06MP/E –Yield –

Fundamental chart

Pick a measure to chart its full history

$14.56MFY2025, +8.9% a year since FY2011

See a number that looks wrong?